title: [Development of arterial thrombus of Mucorales hyphae during deferoxamine therapy in a patient with aplastic anemia in transformation to myelodysplastic syndrome].
abstract: A 58-year-old woman with a diagnosis of aplastic anemia had been treated with anabolic steroid for mild anemia in 1984. In May 1995, pancytopenia progressed and the patient became dependent on red blood cell transfusions. Chromosome analysis of bone marrow cells revealed trisomy 8 and the patient was thought to have aplastic anemia in transformation to myelodysplastic syndrome. In July 1996, deferoxamine was administered for iron overload. The patient was admitted because of pneumonia on July 31, 1998. Chest computed tomograms showed arteriothrombus of the right pulmonary artery and pulmonary mycosis. Although an antifungal agent was administered, the patient experienced respiratory failure and eventually died of hypovolemic shock due to gastric bleeding from a Dieulafoy ulcer. Autopsy revealed arteriothrombus of hyphae of Mucorales in the right pulmonary artery and right renal artery branch. Cases of mucormycosis occurring in dialysis patients receiving deferoxamine have recently appeared in the literature. Deferoxamine may be a risk factor for mucormycosis. Deferoxamine has been also used in the treatment of iron overload patients with aplastic anemia. Four cases of mucormycosis developing in such patients have been reported in Japan including this case. There may be a relationship between mucormycosis and deferoxamine in patients with aplastic anemia.
authors.affiliation: Department of Hematology, Nagoya Ekisaikai Hospital.
authors.forename: Y
authors.initials: Y
authors.lastname: Miyata
authors.forename: T
authors.initials: T
authors.lastname: Kajiguchi
authors.forename: M
authors.initials: M
authors.lastname: Saito
authors.forename: H
authors.initials: H
authors.lastname: Takeyama
mesh_terms: D000741:Anemia, Aplastic / Q000473:pathology*; D002614:Chelating Agents / Q000009:adverse effects*; D003676:Deferoxamine / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D019190:Iron Overload / Q000188:drug therapy; D008875:Middle Aged; D009091:Mucormycosis / Q000209:etiology*; D009190:Myelodysplastic Syndromes / Q000473:pathology*; D011651:Pulmonary Artery; D012077:Renal Artery; D012307:Risk Factors; D013927:Thrombosis / Q000209:etiology*
chemical_list: D002614:Chelating Agents; D003676:Deferoxamine